首页 > 最新文献
paperpass

The female patient最新文献

英文 中文
Patient-Centered Core Impact Sets: What They are and Why We Need Them 以患者为中心的核心影响集:它们是什么以及我们为什么需要它们
Pub Date : 2022-06-02 DOI: 10.1007/s40271-022-00583-x
E. Perfetto, Elisabeth M. Oehrlein, T. Love, S. Schoch, Annie Kennedy, J. Bright
{"title":"Patient-Centered Core Impact Sets: What They are and Why We Need Them","authors":"E. Perfetto, Elisabeth M. Oehrlein, T. Love, S. Schoch, Annie Kennedy, J. Bright","doi":"10.1007/s40271-022-00583-x","DOIUrl":"https://doi.org/10.1007/s40271-022-00583-x","url":null,"abstract":"","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"89 12 1","pages":"619 - 627"},"PeriodicalIF":0.0,"publicationDate":"2022-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87711902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
What Matters for Evaluating the Quality of Mental Healthcare? Identifying Important Aspects in Qualitative Focus Groups with Service Users and Frontline Mental Health Professionals 评价精神卫生服务质量的重要因素是什么?与服务使用者和前线精神卫生专业人员定性焦点小组确定重要方面
Pub Date : 2022-05-06 DOI: 10.1007/s40271-022-00580-0
P. Powell, D. Rowen
{"title":"What Matters for Evaluating the Quality of Mental Healthcare? Identifying Important Aspects in Qualitative Focus Groups with Service Users and Frontline Mental Health Professionals","authors":"P. Powell, D. Rowen","doi":"10.1007/s40271-022-00580-0","DOIUrl":"https://doi.org/10.1007/s40271-022-00580-0","url":null,"abstract":"","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"273 1","pages":"669 - 678"},"PeriodicalIF":0.0,"publicationDate":"2022-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84409611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes 对替西帕肽治疗2型糖尿病临床试验患者体验的调查
Pub Date : 2022-05-01 DOI: 10.1007/s40271-022-00578-8
L. Matza, K. Stewart, L. F. Landó, Hiren Patel, K. Boye
{"title":"Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes","authors":"L. Matza, K. Stewart, L. F. Landó, Hiren Patel, K. Boye","doi":"10.1007/s40271-022-00578-8","DOIUrl":"https://doi.org/10.1007/s40271-022-00578-8","url":null,"abstract":"","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"25 1","pages":"367 - 377"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89581832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
A Comparison of Caregiver and Patient Preferences for Treating Duchenne Muscular Dystrophy 护理者与患者治疗杜氏肌营养不良偏好的比较
Pub Date : 2022-03-04 DOI: 10.1007/s40271-022-00574-y
Norah L. Crossnohere, R. Fischer, E. Vroom, P. Furlong, John F. P. Bridges
{"title":"A Comparison of Caregiver and Patient Preferences for Treating Duchenne Muscular Dystrophy","authors":"Norah L. Crossnohere, R. Fischer, E. Vroom, P. Furlong, John F. P. Bridges","doi":"10.1007/s40271-022-00574-y","DOIUrl":"https://doi.org/10.1007/s40271-022-00574-y","url":null,"abstract":"","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"15 1","pages":"577 - 588"},"PeriodicalIF":0.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78668751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Long COVID Citizen Scientists: Developing a Needs-Based Research Agenda by Persons Affected by Long COVID 长期COVID公民科学家:受长期COVID影响的人制定基于需求的研究议程
Pub Date : 2021-12-08 DOI: 10.1007/s40271-022-00579-7
S. Ziegler, A. Raineri, V. Nittas, N. Rangelov, Fabian Vollrath, Chantal Britt, M. Puhan
{"title":"Long COVID Citizen Scientists: Developing a Needs-Based Research Agenda by Persons Affected by Long COVID","authors":"S. Ziegler, A. Raineri, V. Nittas, N. Rangelov, Fabian Vollrath, Chantal Britt, M. Puhan","doi":"10.1007/s40271-022-00579-7","DOIUrl":"https://doi.org/10.1007/s40271-022-00579-7","url":null,"abstract":"","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"85 1","pages":"565 - 576"},"PeriodicalIF":0.0,"publicationDate":"2021-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80483651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Patient Perspectives on Novel Treatments in Haemophilia: A Qualitative Study. 患者对血友病新疗法的看法:一项定性研究。
Pub Date : 2020-04-01 DOI: 10.1007/s40271-019-00395-6
Erna C van Balen, Marjolein L Wesselo, Bridget L Baker, Marjan J Westerman, Michiel Coppens, Cees Smit, Mariëtte H E Driessens, Frank W G Leebeek, Johanna G van der Bom, Samantha C Gouw

Background and objective: New treatments for haemophilia are under development or entering the market, including extended half-life products, designer drugs and gene therapy, thereby increasing treatment options for haemophilia. It is currently unknown how people with haemophilia decide whether to switch to a new treatment. Therefore, the objective of this study was to explore what factors may play a role when Dutch patients and parents of boys with moderate or severe haemophilia make decisions about whether to switch to a different treatment, and how disease and treatment characteristics may affect these decisions. This may aid clinical teams in tailored information provision and shared decision making.

Methods: We conducted interviews among adults with moderately severe or severe haemophilia and parents of young boys with severe haemophilia. We aimed to include participants from a variety of backgrounds in terms of involvement in the haemophilia community, age, treatment centre and treatments. Participants were recruited through the Netherlands Haemophilia Society and a haemophilia treatment centre. Semi-structured interviews were recorded and transcribed verbatim. Thematic content analysis was used to analyse the data.

Results: Twelve people with haemophilia and two mothers of boys with haemophilia were included. In general, participants reported to be satisfied with their current treatment. However, they considered ease of use of the medication (fewer injections, easier handling, alternative administration) an added value of new treatments. Participants were aware of the high cost of coagulation factor products and some expressed their concern about the Netherlands Haemophilia Society's long-term willingness to pay for current and novel treatments, especially for increased usage due to high-risk activities. Participants also expressed their concerns about the short- and long-term safety of new treatments and believed the effects of gene therapy were not yet fully understood. Participants expected their treatment team to inform them when a particular new treatment would be suitable for them.

Conclusions: With the number of treatment options set to increase, it is important for healthcare providers to be aware of how patient experiences shape patients' decisions about new therapies.

背景和目的:血友病的新治疗方法正在开发或进入市场,包括延长半衰期的产品、设计药物和基因治疗,从而增加了血友病的治疗选择。目前尚不清楚血友病患者如何决定是否改用一种新的治疗方法。因此,本研究的目的是探讨当荷兰患者和患有中度或重度血友病的男孩的父母决定是否切换到不同的治疗方法时,哪些因素可能起作用,以及疾病和治疗特征如何影响这些决定。这可能有助于临床团队提供量身定制的信息和共同决策。方法:我们对患有中度或重度血友病的成年人以及患有严重血友病的男孩的父母进行了访谈。我们的目标是包括来自血友病社区、年龄、治疗中心和治疗方面的各种背景的参与者。参与者是通过荷兰血友病协会和血友病治疗中心招募的。半结构化的访谈被逐字记录和转录。采用主题内容分析法对数据进行分析。结果:12名血友病患者和2名患有血友病男孩的母亲。总的来说,参与者对他们目前的治疗感到满意。然而,他们认为药物使用方便(注射次数少,操作更容易,可选择的给药)是新疗法的附加价值。与会者意识到凝血因子产品的高成本,一些人表达了他们对荷兰血友病协会长期愿意为当前和新型治疗付费的担忧,特别是由于高风险活动而增加的使用。与会者还表达了他们对新疗法的短期和长期安全性的担忧,并认为基因疗法的效果尚未完全了解。参与者希望他们的治疗团队在特定的新治疗方法适合他们时通知他们。结论:随着治疗选择的数量增加,医疗保健提供者了解患者的经历如何影响患者对新疗法的决定是很重要的。
{"title":"Patient Perspectives on Novel Treatments in Haemophilia: A Qualitative Study.","authors":"Erna C van Balen, Marjolein L Wesselo, Bridget L Baker, Marjan J Westerman, Michiel Coppens, Cees Smit, Mariëtte H E Driessens, Frank W G Leebeek, Johanna G van der Bom, Samantha C Gouw","doi":"10.1007/s40271-019-00395-6","DOIUrl":"10.1007/s40271-019-00395-6","url":null,"abstract":"<p><strong>Background and objective: </strong>New treatments for haemophilia are under development or entering the market, including extended half-life products, designer drugs and gene therapy, thereby increasing treatment options for haemophilia. It is currently unknown how people with haemophilia decide whether to switch to a new treatment. Therefore, the objective of this study was to explore what factors may play a role when Dutch patients and parents of boys with moderate or severe haemophilia make decisions about whether to switch to a different treatment, and how disease and treatment characteristics may affect these decisions. This may aid clinical teams in tailored information provision and shared decision making.</p><p><strong>Methods: </strong>We conducted interviews among adults with moderately severe or severe haemophilia and parents of young boys with severe haemophilia. We aimed to include participants from a variety of backgrounds in terms of involvement in the haemophilia community, age, treatment centre and treatments. Participants were recruited through the Netherlands Haemophilia Society and a haemophilia treatment centre. Semi-structured interviews were recorded and transcribed verbatim. Thematic content analysis was used to analyse the data.</p><p><strong>Results: </strong>Twelve people with haemophilia and two mothers of boys with haemophilia were included. In general, participants reported to be satisfied with their current treatment. However, they considered ease of use of the medication (fewer injections, easier handling, alternative administration) an added value of new treatments. Participants were aware of the high cost of coagulation factor products and some expressed their concern about the Netherlands Haemophilia Society's long-term willingness to pay for current and novel treatments, especially for increased usage due to high-risk activities. Participants also expressed their concerns about the short- and long-term safety of new treatments and believed the effects of gene therapy were not yet fully understood. Participants expected their treatment team to inform them when a particular new treatment would be suitable for them.</p><p><strong>Conclusions: </strong>With the number of treatment options set to increase, it is important for healthcare providers to be aware of how patient experiences shape patients' decisions about new therapies.</p>","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"76 1","pages":"201-210"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90488101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies. 一图胜千言:调查培训材料在国家偏好研究中的作用。
Pub Date : 2020-04-01 DOI: 10.1007/s40271-019-00391-w
Caroline M Vass, Niall J Davison, Geert Vander Stichele, Katherine Payne

Background: Online survey-based methods are increasingly used to elicit preferences for healthcare. This digitization creates an opportunity for interactive survey elements, potentially improving respondents' understanding and/or engagement.

Objective: Our objective was to understand whether, and how, training materials in a survey influenced stated preferences.

Methods: An online discrete-choice experiment (DCE) was designed to elicit public preferences for a new targeted approach to prescribing biologics ("biologic calculator") for rheumatoid arthritis (RA) compared with conventional prescribing. The DCE presented three alternatives, two biologic calculators and a conventional approach (opt out), described by five attributes: delay to treatment, positive predictive value, negative predictive value, infection risk, and cost saving to the national health service. Respondents were randomized to receive training materials as plain text or an animated storyline. Training materials contained information about RA and approaches to treatment and described the biologic calculator. Background questions included sociodemographics and self-reported measures of task difficulty and attribute non-attendance. DCE data were analyzed using conditional and heteroskedastic conditional logit (HCL) models.

Results: In total, 300 respondents completed the DCE, receiving either plain text (n = 158) or the animated storyline (n = 142). The HCL showed the estimated coefficients for all attributes aligned with a priori expectations and were statistically significant. The scale term was statistically significant, indicating that respondents who received plain-text materials had more random choices. Further tests suggested preference homogeneity after accounting for differences in scale.

Conclusions: Using animated training materials did not change the preferences of respondents, but they appeared to improve choice consistency, potentially allowing researchers to include more complex designs with increased numbers of attributes, levels, alternatives or choice sets.

背景:基于在线调查的方法越来越多地用于引出对医疗保健的偏好。这种数字化为交互式调查元素创造了机会,有可能提高受访者的理解和/或参与度。目的:我们的目的是了解调查中的培训材料是否以及如何影响陈述的偏好。方法:设计一项在线离散选择实验(DCE),以引起公众对类风湿关节炎(RA)处方生物制剂(“生物计算器”)的新靶向方法的偏好,与传统处方相比。DCE提出了三种替代方案,两种生物计算器和一种传统方法(选择退出),用五个属性来描述:延迟治疗、阳性预测值、阴性预测值、感染风险和为国家卫生服务节省成本。受访者被随机分配接受纯文本或动画故事情节的培训材料。培训材料包含有关类风湿性关节炎的信息和治疗方法,并描述了生物计算器。背景问题包括社会人口统计学和自我报告的任务难度和属性不出席措施。DCE数据采用条件和异方差条件logit (HCL)模型进行分析。结果:共有300名受访者完成了DCE,接受了纯文本(n = 158)或动画故事情节(n = 142)。HCL显示所有属性的估计系数与先验预期一致,并且具有统计学意义。量表项有统计学意义,说明收到纯文本材料的被调查者有更多的随机选择。进一步的测试表明,在考虑尺度差异后,偏好同质性。结论:使用动画训练材料并没有改变受访者的偏好,但它们似乎提高了选择的一致性,潜在地允许研究人员加入更复杂的设计,增加属性、级别、选择或选择集的数量。
{"title":"A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies.","authors":"Caroline M Vass, Niall J Davison, Geert Vander Stichele, Katherine Payne","doi":"10.1007/s40271-019-00391-w","DOIUrl":"10.1007/s40271-019-00391-w","url":null,"abstract":"<p><strong>Background: </strong>Online survey-based methods are increasingly used to elicit preferences for healthcare. This digitization creates an opportunity for interactive survey elements, potentially improving respondents' understanding and/or engagement.</p><p><strong>Objective: </strong>Our objective was to understand whether, and how, training materials in a survey influenced stated preferences.</p><p><strong>Methods: </strong>An online discrete-choice experiment (DCE) was designed to elicit public preferences for a new targeted approach to prescribing biologics (\"biologic calculator\") for rheumatoid arthritis (RA) compared with conventional prescribing. The DCE presented three alternatives, two biologic calculators and a conventional approach (opt out), described by five attributes: delay to treatment, positive predictive value, negative predictive value, infection risk, and cost saving to the national health service. Respondents were randomized to receive training materials as plain text or an animated storyline. Training materials contained information about RA and approaches to treatment and described the biologic calculator. Background questions included sociodemographics and self-reported measures of task difficulty and attribute non-attendance. DCE data were analyzed using conditional and heteroskedastic conditional logit (HCL) models.</p><p><strong>Results: </strong>In total, 300 respondents completed the DCE, receiving either plain text (n = 158) or the animated storyline (n = 142). The HCL showed the estimated coefficients for all attributes aligned with a priori expectations and were statistically significant. The scale term was statistically significant, indicating that respondents who received plain-text materials had more random choices. Further tests suggested preference homogeneity after accounting for differences in scale.</p><p><strong>Conclusions: </strong>Using animated training materials did not change the preferences of respondents, but they appeared to improve choice consistency, potentially allowing researchers to include more complex designs with increased numbers of attributes, levels, alternatives or choice sets.</p>","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"155 1","pages":"163-173"},"PeriodicalIF":0.0,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79771932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Patient Perspective: A Matter of Minutes 病人的观点:几分钟的问题
Pub Date : 2019-11-29 DOI: 10.1007/s40271-019-00399-2
R. Falchetto
{"title":"The Patient Perspective: A Matter of Minutes","authors":"R. Falchetto","doi":"10.1007/s40271-019-00399-2","DOIUrl":"https://doi.org/10.1007/s40271-019-00399-2","url":null,"abstract":"","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"57 1","pages":"1 - 6"},"PeriodicalIF":0.0,"publicationDate":"2019-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88036349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
“Lower abdominal pains, as if I was being squeezed…in a clamp”: A Qualitative Analysis of Symptoms, Patient-Perceived Side Effects and Impacts of Ovarian Cancer “下腹部疼痛,好像我被夹住了”:卵巢癌的症状、患者感觉的副作用和影响的定性分析
Pub Date : 2019-11-06 DOI: 10.1007/s40271-019-00393-8
Mona L. Martin, K. Halling, D. Eek, M. Reaney
{"title":"“Lower abdominal pains, as if I was being squeezed…in a clamp”: A Qualitative Analysis of Symptoms, Patient-Perceived Side Effects and Impacts of Ovarian Cancer","authors":"Mona L. Martin, K. Halling, D. Eek, M. Reaney","doi":"10.1007/s40271-019-00393-8","DOIUrl":"https://doi.org/10.1007/s40271-019-00393-8","url":null,"abstract":"","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"56 1","pages":"189 - 200"},"PeriodicalIF":0.0,"publicationDate":"2019-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82300276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom) 评估患者对甲状旁腺功能减退症状的体验:甲状旁腺功能减退患者体验量表-症状(HPES-Symptom)的发展
Pub Date : 2019-09-25 DOI: 10.1007/s40271-019-00388-5
M. Brod, L. Waldman, Alden Smith, D. Karpf
{"title":"Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom)","authors":"M. Brod, L. Waldman, Alden Smith, D. Karpf","doi":"10.1007/s40271-019-00388-5","DOIUrl":"https://doi.org/10.1007/s40271-019-00388-5","url":null,"abstract":"","PeriodicalId":89489,"journal":{"name":"The female patient","volume":"1 1","pages":"151 - 162"},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76134833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
期刊
The female patient
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1